HU9601685D0 - 4,5-diaryloxazole derivatives - Google Patents

4,5-diaryloxazole derivatives

Info

Publication number: HU9601685D0
Authority: HU; Hungary
Prior art keywords: aryl; lower alkylene; diaryloxazole; derivatives; suitable substituent
Prior art date: 1993-12-20

Application number

HU9601685A

Other languages

English (en)

Other versions

HUT76341A (en

Inventor

Kouji Hattori

Masanobu Nagano

Osamu Okitsu

Seiichiro Tabuchi

Kiyoshi Taniguchi

Kazunori Tsubaki

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-20

Filing date

1994-12-16

Publication date

1996-08-28

1993-12-20 Priority claimed from GB939325962A external-priority patent/GB9325962D0/en

1994-11-07 Priority claimed from GB9422404A external-priority patent/GB9422404D0/en

1994-12-16 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1996-08-28 Publication of HU9601685D0 publication Critical patent/HU9601685D0/hu

1997-08-28 Publication of HUT76341A publication Critical patent/HUT76341A/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

HU9601685A 1993-12-20 1994-12-16 Process for preparation of 4,5-diaryloxazole derivatives and pharmaceutical compositions containing them HUT76341A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB939325962A GB9325962D0 (en)	1993-12-20	1993-12-20	Heterocyclic compounds
GB9422404A GB9422404D0 (en)	1994-11-07	1994-11-07	Heterocyclic compounds

Publications (2)

Publication Number	Publication Date
HU9601685D0 true HU9601685D0 (en)	1996-08-28
HUT76341A HUT76341A (en)	1997-08-28

Family

ID=26304051

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU9601685A HUT76341A (en)	1993-12-20	1994-12-16	Process for preparation of 4,5-diaryloxazole derivatives and pharmaceutical compositions containing them

Country Status (17)

Country	Link
US (1)	US6025375A (hu)
EP (1)	EP0736018B1 (hu)
JP (1)	JPH09506894A (hu)
KR (1)	KR100345943B1 (hu)
CN (2)	CN1046714C (hu)
AT (1)	ATE194335T1 (hu)
AU (1)	AU686286B2 (hu)
CA (1)	CA2179399A1 (hu)
DE (1)	DE69425162T2 (hu)
DK (1)	DK0736018T3 (hu)
ES (1)	ES2147836T3 (hu)
GR (1)	GR3034542T3 (hu)
HU (1)	HUT76341A (hu)
PT (1)	PT736018E (hu)
RU (1)	RU2176640C2 (hu)
TW (1)	TW374086B (hu)
WO (1)	WO1995017393A1 (hu)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW401408B (en) *	1995-07-21	2000-08-11	Fujisawa Pharmaceutical Co	Heterocyclic compounds having prostaglandin I2 agonism
AUPO713297A0 (en) *	1997-06-02	1997-06-26	Fujisawa Pharmaceutical Co., Ltd.	Oxazole compound
GB9720270D0 (en)	1997-09-25	1997-11-26	Pharmagene Lab Limited	Medicaments for the treatment of migraine
AUPP003297A0 (en) *	1997-10-27	1997-11-20	Fujisawa Pharmaceutical Co., Ltd.	4,5-diaryloxazole compounds
AUPP029197A0 (en)	1997-11-10	1997-12-04	Fujisawa Pharmaceutical Co., Ltd.	Benzocycloheptene derivatives
AUPP109097A0 (en)	1997-12-22	1998-01-22	Fujisawa Pharmaceutical Co., Ltd.	Napthalene derivatives
BR9913833A (pt)	1998-09-17	2001-05-29	Bristol Myers Squibb Co	Método para tratar diabetes, empregando em inibidor de ap2 e combinação
US7358254B2 (en)	2001-07-13	2008-04-15	Bristol-Myers Squibb Company	Method for treating atherosclerosis employing an aP2 inhibitor and combination
AUPP608898A0 (en) *	1998-09-23	1998-10-15	Fujisawa Pharmaceutical Co., Ltd.	New use of prostaglandin E2 antagonists
US6437146B1 (en)	1998-09-25	2002-08-20	Fujisawa Pharmaceutical Co., Ltd.	Oxazole compounds as prostaglandin e2 agonists or antagonists
AU2005201289B2 (en) *	1999-02-12	2008-04-17	President And Fellows Of Harvard College	Inhibiting formation of atherosclerotic lesions
IL145122A0 (en)	1999-03-05	2002-06-30	Procter & Gamble	C16 unsaturated fp-selective prostaglandin analogs
KR20020015345A (ko) *	1999-06-21	2002-02-27	후지야마 아키라	피부 궤양 치료제
US6894175B1 (en) *	1999-08-04	2005-05-17	The Procter & Gamble Company	2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
AUPQ253199A0 (en) *	1999-08-30	1999-09-23	Fujisawa Pharmaceutical Co., Ltd.	Non-prostanoid prostaglandin I2-agonist
US7390824B1 (en)	1999-09-07	2008-06-24	Bristol-Myers Squibb Company	Method for treating diabetes employing an aP2 inhibitor and combination
DE60038902D1 (de) *	2000-03-24	2008-06-26	Asterand Uk Ltd	Verwendung von prostanoid-ep4-rezeptor-antagonisten zur behandlung von kopfschmerzen und nachweisverfahren für solche antagonisten
US20020013294A1 (en)	2000-03-31	2002-01-31	Delong Mitchell Anthony	Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) *	2000-03-31	2002-11-21	Delong Michell Anthony	Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) *	2000-03-31	2002-03-28	Delong Mitchell Anthony	Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020146439A1 (en) *	2000-03-31	2002-10-10	Delong Mitchell Anthony	Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20040116530A1 (en) *	2001-04-18	2004-06-17	Noriaki Maeda	Tissue fibrosis inhibitors
AU2003216920A1 (en)	2002-04-08	2003-10-20	Glaxo Group Limited	(2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
GB0225548D0 (en)	2002-11-01	2002-12-11	Glaxo Group Ltd	Compounds
TW200505446A (en) *	2003-01-17	2005-02-16	Fuj Isawa Pharmaceutical Co Ltd	Inhibitor of cox
US7439372B2 (en) *	2006-05-03	2008-10-21	Allergan, Inc.	Therapeutic compounds
US20090016981A1 (en)	2006-05-03	2009-01-15	Allergan, Inc.	Therapeutic compounds
US8217027B2 (en) *	2006-12-21	2012-07-10	Abbott Laboratories	Sphingosine-1-phosphate receptor agonist and antagonist compounds
CA2676252A1 (en)	2007-01-25	2008-07-31	Allergan, Inc.	Substituted arylcyclopentenes as therapeutic agents
US9365485B2 (en)	2007-01-25	2016-06-14	Allergan, Inc.	Substituted arylcyclopentenes as therapeutic agents
US8722739B2 (en)	2008-10-29	2014-05-13	Novaer Holdings, Inc.	Amino acid salts of prostaglandins
US8623918B2 (en) *	2008-10-29	2014-01-07	Novaer Holdings, Inc.	Amino acid salts of prostaglandins
TWI435874B (zh)	2008-10-31	2014-05-01	Toray Industries	環己烷衍生物及其醫藥用途
WO2010122169A1 (en) *	2009-04-24	2010-10-28	Basf Se	5-mercapto- [1,2, 4] triazole compounds and their agricultural and pharmaceutical uses
US8969573B2 (en) *	2010-06-28	2015-03-03	President And Fellows Of Harvard College	Compounds for the inhibition of cellular proliferation
WO2014194209A1 (en)	2013-05-31	2014-12-04	Allergan, Inc.	Substituted cyclopentenes as therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3578671A (en) *	1967-11-06	1971-05-11	Wyeth John & Brother Ltd	Oxazoles
US4072689A (en) *	1973-02-22	1978-02-07	Gruppo Lepetit S.P.A.	Monoamino 2,4,5-trisubstituted oxazoles
NZ236474A (en) *	1989-12-20	1993-07-27	Bristol Myers Squibb Co	4,5-diphenyl-2-oxazole octanoic, nonanoic and decanoic acid and ester derivatives, preparation and pharmaceutical compositions thereof
US5348969A (en) *	1992-04-03	1994-09-20	Bristol-Myers Squibb Company	Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
US5763489A (en) *	1994-03-10	1998-06-09	Fujisawa Pharmaceutical Co., Ltd.	Naphthalene derivatives as prostaglandin I2 agonsists

1994
- 1994-12-16 WO PCT/JP1994/002116 patent/WO1995017393A1/en active IP Right Grant
- 1994-12-16 DE DE69425162T patent/DE69425162T2/de not_active Expired - Fee Related
- 1994-12-16 ES ES95902969T patent/ES2147836T3/es not_active Expired - Lifetime
- 1994-12-16 CN CN94194557A patent/CN1046714C/zh not_active Expired - Fee Related
- 1994-12-16 PT PT95902969T patent/PT736018E/pt unknown
- 1994-12-16 CA CA002179399A patent/CA2179399A1/en not_active Abandoned
- 1994-12-16 AU AU12006/95A patent/AU686286B2/en not_active Ceased
- 1994-12-16 HU HU9601685A patent/HUT76341A/hu unknown
- 1994-12-16 RU RU96115170/04A patent/RU2176640C2/ru not_active IP Right Cessation
- 1994-12-16 AT AT95902969T patent/ATE194335T1/de not_active IP Right Cessation
- 1994-12-16 JP JP7517312A patent/JPH09506894A/ja not_active Ceased
- 1994-12-16 KR KR1019960703222A patent/KR100345943B1/ko not_active IP Right Cessation
- 1994-12-16 EP EP95902969A patent/EP0736018B1/en not_active Expired - Lifetime
- 1994-12-16 DK DK95902969T patent/DK0736018T3/da active
- 1994-12-17 TW TW083111798A patent/TW374086B/zh active
1998
- 1998-06-05 US US09/092,027 patent/US6025375A/en not_active Expired - Fee Related
- 1998-07-25 CN CN98116704A patent/CN1090184C/zh not_active Expired - Fee Related
2000
- 2000-10-04 GR GR20000402232T patent/GR3034542T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
RU2176640C2 (ru)	2001-12-10
WO1995017393A1 (en)	1995-06-29
CN1138328A (zh)	1996-12-18
DE69425162T2 (de)	2000-12-21
DE69425162D1 (de)	2000-08-10
KR960706482A (ko)	1996-12-09
EP0736018B1 (en)	2000-07-05
HUT76341A (en)	1997-08-28
TW374086B (en)	1999-11-11
ES2147836T3 (es)	2000-10-01
ATE194335T1 (de)	2000-07-15
DK0736018T3 (da)	2000-09-18
GR3034542T3 (en)	2001-01-31
AU686286B2 (en)	1998-02-05
PT736018E (pt)	2000-10-31
US6025375A (en)	2000-02-15
KR100345943B1 (ko)	2002-11-30
CN1046714C (zh)	1999-11-24
CN1090184C (zh)	2002-09-04
JPH09506894A (ja)	1997-07-08
EP0736018A1 (en)	1996-10-09
AU1200695A (en)	1995-07-10
CN1229795A (zh)	1999-09-29
CA2179399A1 (en)	1995-06-29

Publication	Publication Date	Title
HU9601685D0 (en)	1996-08-28	4,5-diaryloxazole derivatives
MX9800577A (es)	1998-04-30	Derivados de 4,5-diaril oxazol.
IL108562A (en)	1997-06-10	7, 8-diaryl-1,2,3,4- terahydropyrazolo- £5,1-c\| £1,2,4\| triazine derivatives, methods for the preparation thereof and pharmaceutical compositions containing them
WO1996016981A3 (en)	1996-09-06	Peptide compounds for prevention and/or treatment of no-mediated diseases
EP0669324A4 (en)	1996-04-03	CHINAZOLIN DERIVATIVES.
ES2182852T3 (es)	2003-03-16	Derivados de prolinamida.
IL101785A0 (en)	1992-12-30	Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
TW282456B (hu)	1996-08-01
AU8046891A (en)	1992-01-23	Pyrazolopyridine compound and processes for preparation thereof
AP9801321A0 (en)	2000-02-14	2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
CA2306782A1 (en)	1999-04-29	Isoquinolines as urokinase inhibitors
ES2093091T3 (es)	1996-12-16	Derivado de glutation.
GB9426090D0 (en)	1995-02-22	Pharmaceutical compounds
FI895139A0 (fi)	1989-10-30	Pyrrolidinderivat.
IE892428L (en)	1990-01-26	Use of imidazopyrazole derivatives as analgesics and¹anti-inflammatory agents
TW360630B (en)	1999-06-11	A secoaporphine compounds on arrhythmia